Sponsor or institution
Clinical trials and research at Obstetrics & Gynecology Hospital of Fudan University
As of November 12, 2026, Find a Trial lists 9 clinical trials run by Obstetrics & Gynecology Hospital of Fudan University that are recruiting, in China. By phase: Phase 2 (3), Phase 2/3 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 9Clinical trials
- 1Country
Newest trials
All recruiting trials (9)
-
Intra-operative dual laparoscopy and neo-rectoscopy (IDLnR) versus conventional laparoscopy for bowel endometriosis
We will test whether adding intra-operative dual laparoscopy and neo-rectoscopy (IDLnR) to surgery for women with bowel endometriosis improves bowel function six months after the operation compared with conventional laparoscopy.
-
cCTL plus immunotherapy for advanced gynecologic cancers
This trial will test whether injecting tumor-specific cytotoxic T lymphocytes (cCTL) together with immunotherapy helps people with advanced gynecologic cancers who have not responded to standard treatments.
-
Weekly paclitaxel or nab-paclitaxel with pembrolizumab and mirabegron for recurrent ovarian cancer
This study tests whether weekly paclitaxel or nab-paclitaxel combined with pembrolizumab and daily mirabegron can shrink tumors and be safe for adults with relapsed ovarian cancer.
-
National multicenter cohort of molar pregnancy in China
This project will see how often molar pregnancy turns into cancer and which clinical or pathological factors predict that, by following patients across multiple hospitals in China.
-
Ivonescimab with paclitaxel and cisplatin before type A hysterectomy for Stage IB2/IIA1 (2–4 cm) cervical cancer
This trial will test whether adding ivonescimab to paclitaxel and cisplatin before surgery helps women with 2–4 cm (Stage IB2 or IIA1) cervical cancer shrink tumors so they can have a less radical (type A) hysterectomy.
-
CAR-T cell therapy for advanced gynecological tumors
This study is testing if CAR-T cell therapy can help people with advanced gynecological tumors by seeing how safe it is and how well it works.
-
Combination of Iparomlimab and Tuvonralimab with Chemotherapy for Cervical Cancer
This study is testing whether combining two new immune treatments with standard chemotherapy can help women with locally advanced cervical cancer respond better to treatment before surgery.
-
Exploring new imaging technology for cervical cancer surgery
This study is testing a new imaging technology to help doctors find cancer spread in lymph nodes during cervical cancer surgery to see if it can improve surgery results for patients.
-
Combining pegylated liposomal doxorubicin and adebrelimab with or without mirabegron for relapsed ovarian cancer
This study is testing a new treatment combination for adults with relapsed ovarian cancer to see if adding mirabegron to pegylated liposomal doxorubicin and adebrelimab makes it work better.
Quick answers
How many clinical trials run by Obstetrics & Gynecology Hospital of Fudan University are recruiting right now?
9, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 2/3: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.